Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer. - Matsumoto K; Yamamoto Y; Shiroyama T; Kuge T; Miyazaki A; Komuta K; Tamiya M; Nishino K; Tsukaguchi A; Tamiya A; Mihashi Y; Uchida J; et al. (European journal of cancer (Oxford, England : 1990), 2026)